S.C. Terapia S.A.
S.C. Terapia S.A., a prominent player in the Romanian healthcare sector, is headquartered in Romania and operates extensively across various regions. Founded in 1992, the company has established itself as a leader in the pharmaceutical industry, focusing on the development and distribution of innovative therapeutic solutions. With a diverse portfolio that includes prescription medications, over-the-counter products, and dietary supplements, S.C. Terapia S.A. is renowned for its commitment to quality and efficacy. The company’s unique approach to research and development has led to several key milestones, solidifying its market position as a trusted provider of healthcare solutions. Recognised for its contributions to patient care, S.C. Terapia S.A. continues to advance its mission of improving health outcomes through cutting-edge products and services tailored to meet the needs of healthcare professionals and patients alike.
DitchCarbon Score
How does S.C. Terapia S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
S.C. Terapia S.A.'s score of 24 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
S.C. Terapia S.A.'s reported carbon emissions
S.C. Terapia S.A. currently does not have available carbon emissions data, as no specific figures have been provided. Consequently, there are no reported emissions for the most recent year or any previous years. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as Science-Based Targets Initiative (SBTi) goals or other climate pledges. In the absence of specific emissions data and reduction initiatives, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and reducing their carbon footprints. This trend often includes setting ambitious targets for emissions reductions across Scope 1, 2, and 3 emissions, which encompass direct emissions from owned or controlled sources, indirect emissions from the generation of purchased energy, and other indirect emissions in the value chain. As S.C. Terapia S.A. continues to navigate the evolving landscape of climate responsibility, stakeholders may look forward to future disclosures regarding their emissions and sustainability commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
S.C. Terapia S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
